Tianyin Pharmaceutical Co., Inc. Provides Fiscal 201...( CHENGDU China June 18/ PRNewswire-A...),Health

    CHENGDU, China, June 18/ PRNewswire-Asia-FirstCall/ --

    -- Management expects to report revenues of approximately
       $42 million and net income of approximately $7.5 million for
       the Fiscal Year which ends June 30, 2009.  Fourth quarter
       revenue and net income of approximately $12.4 million and
       $1.8 million, respectively.

    -- Fiscal 2010 Guidance of $59 million in revenue and
       $10.5 million in net income, representing approximately 40%
       and 42% growth over estimated fiscal 2009.

Tianyin Pharmaceutical, Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced its unaudited, preliminary financial results for the fiscal year ended June 30, 2009, and fiscal 2010 financial guidance. The Company plans to announce the final results and to hold a conference call for 2009 in September.

Fiscal Year 2009 Financial Highlights

Based on preliminary financial data, Tianyin expects to report fiscal 2009 (year ending June 30) revenues of $42 million and net income of at least $7.5 million, representing 25% and 26% year over year growth respectively. Ginko Mihuan is expected to represent approximately 23% of total revenues. This data is subject to normal audit adjustments and therefore may be changed when reported in Tianyin's Annual Report on Form 10-K for the fiscal year ended June 30, 2009.

"We are very pleased with these anticipated results, which have been supported by targeted sales promotion of new and existing products, including Ginko Mihuan, and supported by the further expansion of our sales team and distribution channels." Dr. Jiang, Chairman and CEO of Tianyin commented. "During the 2009 fiscal year, our advertising expense increased 15% to $1.8
'/>"/>